BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Tofacitinib
1
Tofacitinib for ulcerative colitis: A promising treatment option
10/16/2024 6:29:25 AM | Browse: 61 | Download: 336
2
Precautions before starting tofacitinib in persons with rheumatoid arthritis
12/26/2022 6:23:38 PM | Browse: 271 | Download: 664
3
Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report
9/29/2022 9:17:30 AM | Browse: 388 | Download: 1300
4
Recurrent herpes zoster in a rheumatoid arthritis patient treated with tofacitinib: A case report and review of the literature
8/16/2022 1:35:32 AM | Browse: 327 | Download: 997
5
Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study
6/8/2022 2:31:10 AM | Browse: 515 | Download: 1388
6
Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report
12/19/2020 4:08:52 PM | Browse: 662 | Download: 1963
7
Tofacitinib for the treatment of ulcerative colitis: A review of the literature
9/3/2019 7:56:59 AM | Browse: 882 | Download: 1384
8
Novel oral-targeted therapies for mucosal healing in ulcerative colitis
12/21/2018 10:07:19 AM | Browse: 1112 | Download: 1414
9
Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis
12/2/2015 12:24:00 PM | Browse: 1338 | Download: 1504
10
When combination therapy isn’t working: Emerging therapies for the management of inflammatory bowel disease
9/3/2014 2:27:00 PM | Browse: 1018 | Download: 1328
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345